STEAP1 and ovarian cancer: The STEAP1 protein is overexpressed in prostate, bladder, renal, breast, testicular, pancreatic, cervical, and ovarian cancer, making STEAP1 an attractive candidate for a wide range of cancer immunotherapies [15,29,30,31,32,33].